<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Tanycytes in Energy Balance and Neurodegeneration</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Ependymal Glial Cells</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Third ventricle, hypothalamic region</td>
</tr>
<tr>
<td class="label">Cell Types</td>
<td>Alpha tanycytes, Beta tanycytes</td>
</tr>
<tr>
<td class="label">Key Markers</td>
<td>Vimentin, Nestin, [GFAP](/entities/gfap) (reactive)</td>
</tr>
<tr>
<td class="label">Primary Functions</td>
<td>Energy sensing, Neurogenesis, CSF-brain communication</td>
</tr>
</table>
Tanycytes are specialized ependymal glial cells that line the floor of the third ventricle and extend their processes into the hypothalamic parenchyma. These remarkable cells serve as critical interface between the cerebrospinal fluid (CSF) and brain tissue, playing essential roles in energy homeostasis, neurogenesis, and neuroendocrine regulation. In recent years, research has increasingly revealed their involvement in neurodegenerative disease processes, making them important therapeutic targets for conditions such as Alzheimer's disease (AD), Parkinson's disease (PD), and metabolic disorders affecting the brain. [@bolborea2020]
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Tanycytes in Energy Balance and Neurodegeneration</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Ependymal Glial Cells</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Third ventricle, hypothalamic region</td>
</tr>
<tr>
<td class="label">Cell Types</td>
<td>Alpha tanycytes, Beta tanycytes</td>
</tr>
<tr>
<td class="label">Key Markers</td>
<td>Vimentin, Nestin, [GFAP](/entities/gfap) (reactive)</td>
</tr>
<tr>
<td class="label">Primary Functions</td>
<td>Energy sensing, Neurogenesis, CSF-brain communication</td>
</tr>
</table>
Tanycytes are specialized ependymal glial cells that line the floor of the third ventricle and extend their processes into the hypothalamic parenchyma. These remarkable cells serve as critical interface between the cerebrospinal fluid (CSF) and brain tissue, playing essential roles in energy homeostasis, neurogenesis, and neuroendocrine regulation. In recent years, research has increasingly revealed their involvement in neurodegenerative disease processes, making them important therapeutic targets for conditions such as Alzheimer's disease (AD), Parkinson's disease (PD), and metabolic disorders affecting the brain. [@bolborea2020]
Tanycytes were first described by Wilhelm His in 1887, but their functional significance has only become appreciated in recent decades with advances in neuroscience research. These cells possess unique morphological features, including a single ventricular process reaching the brain surface and a basal process that contacts blood vessels and [neurons](/entities/neurons) in the hypothalamic nuclei. This strategic positioning allows them to sense circulating metabolic signals and transmit this information to central neural circuits controlling energy balance. [@prevot2018]
Tanycytes are predominantly located in the mediobasal hypothalamus, with highest concentrations in the arcuate nucleus (ARC) and the median eminence. The dorsal region of the third ventricle contains fewer tanycytes, transitioning into typical ependymal cells. Their processes extend throughout the hypothalamic region, forming intimate contacts with neurons in key metabolic centers including the arcuate nucleus, ventromedial hypothalamus, and dorsomedial hypothalamus.
Tanycytes express an impressive array of receptors that allow them to respond to circulating metabolic signals:
These cells express numerous transport systems critical for their barrier and transport functions:
Tanycytes activate multiple intracellular signaling cascades in response to metabolic signals:
Tanycytes serve as crucial transducers of peripheral metabolic information to central neural circuits. They detect changes in circulating glucose, leptin, ghrelin, and other metabolic factors through their ventricular surface, then communicate this information to hypothalamic neurons controlling appetite, energy expenditure, and glucose metabolism. This function is essential for maintaining energy homeostasis and body weight stability.
The tanycytic barrier at the median eminence is particularly important, as it controls the passage of circulating molecules into the hypothalamic parenchyma. This barrier shares characteristics with the [blood-brain barrier](/entities/blood-brain-barrier) but exhibits unique permeability properties that allow selective access of metabolic signals to neuroendocrine neurons. The tight junction proteins claudin-1, claudin-5, and ZO-1 maintain this barrier function while permitting regulated transport.
Alpha tanycytes in the dorsal third ventricle function as neural stem cells capable of generating new neurons throughout life. This neurogenic activity is particularly prominent in the hypothalamic median eminence, where new neurons are incorporated into circuits controlling energy balance. The neurogenic potential of tanycytes decreases with age, and this decline has been implicated in age-related metabolic dysfunction and cognitive decline.
Research has demonstrated that tanycyte-derived neurogenesis contributes to the maintenance of hypothalamic neural circuits and may represent a therapeutic target for neurodegenerative conditions. Growth factors including brain-derived neurotrophic factor (BDNF), fibroblast growth factor (FGF), and epidermal growth factor (EGF) regulate tanycyte proliferation and differentiation.
Tanycytes play essential roles in hypothalamic-pituitary axis regulation by controlling the release of releasing and inhibiting hormones into the pituitary portal system. They express enzymes for thyroid hormone conversion (type 2 deiodinase) and glucocorticoid metabolism (11β-hydroxysteroid dehydrogenase), allowing precise regulation of hormone availability in the hypothalamus.
Tanycyte dysfunction contributes to several aspects of Alzheimer's disease pathophysiology. The hypothalamic-pituitary-adrenal (HPA) axis dysregulation observed in AD patients involves altered tanycytic glucocorticoid metabolism, leading to chronic exposure of hippocampal and cortical neurons to elevated cortisol levels. This glucocorticoid excess promotes amyloid-β production, [tau](/proteins/tau) phosphorylation, and synaptic dysfunction.
Metabolic disturbances common in AD, including insulin resistance and leptin dysfunction, are reflected in altered tanycytic signaling. Research using postmortem human brain tissue has revealed structural abnormalities in tanycytes from AD patients, including reduced process complexity and altered GFAP expression patterns. These changes may contribute to the hypothalamic dysfunction observed in AD, including circadian rhythm disturbances and metabolic syndrome.
The median eminence region shows early pathological changes in AD models, with tanycytic barrier dysfunction allowing inappropriate passage of peripheral molecules into the hypothalamus. This breach may trigger neuroinflammatory responses and accelerate neurodegenerative processes.
While less studied than in AD, tanycytes are increasingly recognized as players in Parkinson's disease pathophysiology. The hypothalamus shows pathological involvement in PD, with studies demonstrating Lewy body pathology in hypothalamic nuclei and altered neurotransmitter levels. Tanycytic dysfunction may contribute to these hypothalamic disturbances, which manifest clinically as sleep disorders, autonomic dysfunction, and metabolic changes in PD patients.
Neuroinflammation in PD affects tanycyte function through several mechanisms. Pro-inflammatory cytokines including IL-1β, TNF-α, and IL-6 alter tanycytic barrier properties and reduce their neurogenic capacity. [Alpha-synuclein](/proteins/alpha-synuclein) pathology, the hallmark of PD, has been detected in hypothalamic regions and may directly affect tanycyte function.
The bidirectional relationship between metabolic syndrome and neurodegenerative diseases involves tanycytic dysfunction as a key mechanism. Obesity, type 2 diabetes, and insulin resistance—all risk factors for AD and PD—are associated with tanycytic inflammation, barrier dysfunction, and altered neurogenesis. Tanycytes in the arcuate nucleus are particularly vulnerable to metabolic insults, as this region has relatively permeable blood vessels allowing direct exposure to circulating factors.
Emerging evidence suggests tanycyte involvement in amyotrophic lateral sclerosis (ALS). The hypothalamus shows atrophy and metabolic dysregulation in ALS patients, with some studies reporting altered tanycytic morphology in postmortem tissue. Given the significant metabolic component of ALS, including weight loss and hypermetabolism, tanycytic dysfunction may contribute to these systemic manifestations.
Tanycytes represent attractive therapeutic targets for neurodegenerative diseases with metabolic components. Strategies under investigation include:
Protecting tanycyte function may provide neuroprotection in neurodegenerative conditions:
Restoring tanycytic barrier function at the median eminence represents a novel therapeutic approach:
Tanycytes exhibit unique electrophysiological properties that relate to their sensory functions. They express various ion channels allowing them to respond to chemical and electrical signals:
While not neurons, tanycytes form extensive connections with neural and vascular elements:
Studying tanycytes requires specialized techniques:
Tanycytes represent a critical interface between metabolism and neurodegeneration, serving as sensors, transducers, and regulators of hypothalamic function. Their involvement in energy homeostasis, neurogenesis, and neuroendocrine regulation positions them as important players in neurodegenerative disease pathophysiology. Understanding tanycytic dysfunction in AD, PD, and related conditions offers novel therapeutic opportunities targeting the metabolic-neurodegenerative axis.
The study of Tanycytes In Energy Balance And Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.